Duke CTSI Special Populations Pilot Agreements [Duke Internal Funding -- For Duke Faculty Only]

Funding Agency:
Duke University

The purpose of the Special Populations Pilot program is to facilitate research that promotes health equity for groups who have traditionally been under-represented in health research or excluded altogether.

The Duke CTSI Special Populations Pilot Agreement provides funding up to $25,000 (direct costs only) to support novel clinical and translational research in its many forms. Projects must show strong potential to inform subsequent grant applications to the NIH or other funding agencies.


  • Mandatory Letter of Intent: December 17, 2019
  • Invitation to Submit Full Application: no later than January 17, 2020
  • Invited Application Submission Deadline: March 17, 2020

Agency Website

Areas of Interest

Submissions must focus on one of the following populations:

  • pediatric populations, adolescents and young adults, or older adults;
  • people with disabilities and/or rare disorders, and/or populations which have been underserved or underrepresented in clinical research (e.g., African Americans, Native Americans, Latinos, rural populations or populations with low socioeconomic status)

Eligibility Requirements

II. Eligibility • Proposals must be submitted by Duke investigators with PI status per Duke’s written policy. Investigators holding an adjunct appointment are not eligible. • Non-Duke faculty may be named as co-investigators with appropriate justification for the collaboration. • More than one proposal may be submitted per faculty member acting as PI, but the faculty member is only eligible to receive one award as PI from this funding mechanism during a given funding cycle. • Applicants are required to submit a mandatory letter of intent (LOI). • Upon conclusion of LOI review, selected applicants will be invited to submit a Full Proposal. All investigators invited to submit a full proposal are required to attend a consultation meeting with the Special Populations team and CERI (if applicable). 



Funding Type





Medical - Clinical Science
Medical - Translational

External Deadline

December 17, 2019